Zishenpingchan granules for the treatment of Parkinson’s disease: a randomized, double-blind, placebo-controlled clinical trial

Levodopa preparations remain the preferred drug for Parkinson’s disease. However, long-term use of levodopa may lead to a series of motor complications. Previous studies have shown that the combination of levodopa and Zishenpingchan granules (consisting of Radix Rehmanniae preparata, Lycium barbarum...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Qing, Yuan, Xiao-Lei, Yuan, Can-Xing, Zhang, Hong-Zhi, Yang, Xu-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065246/
https://www.ncbi.nlm.nih.gov/pubmed/30028337
http://dx.doi.org/10.4103/1673-5374.235075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065246/
https://www.ncbi.nlm.nih.gov/pubmed/30028337
http://dx.doi.org/10.4103/1673-5374.235075

Ejemplares similares